Dr. Choi-Kain is currently the Director of the Gunderson Personality Disorders Institute (GPDI), an internationally recognized center of training for empirically supported treatments for borderline personality disorder (BPD) and research on outcomes as well as the social cognitive mechanisms targeted in these interventions. She is also an Associate Professor of Psychiatry at Harvard Medical School. Her research training began as a post-doctoral fellow under the supervision of John Gunderson, M.D. As PI, co-investigator, and collaborator on several NIMH and donor-funded grants, she participated in studies of neuropsychological and social cognitive correlates of BPD and attachment, in addition to other biologically centered aspects of BPD, including heritability, familial aggregation, and hypothalamic-pituitary-adrenal axis hyperactivity. Dr. Choi-Kain developed an intensive residential treatment program, the Gunderson Residence, a research program, and a training institute offering CME-accredited trainings in MBT, DBT, DBT-PTSD, transference-focused psychotherapy (TFP), and good psychiatric management (GPM). Dr. Choi-Kain has unique expertise regarding these many approaches, enabling her to bring together their common factors in a generic form of more widely available treatment. Dr. Choi-Kain has also written extensively about the problems of access to care and scalability of our armamentarium of BPD treatments. She has edited four books on various applications of Gunderson’s GPM as a public health scalable solution to the demand and supply gap in BPD treatments. Her work and impact on the field has been acknowledged by numerous honors including the Penn Psychotherapy Professorship, Kenneth R. Silk, M.D. Lectureship, Distinguished Psychiatrist Award from UCLA, and the Heinz Kohut Memorial Lectureship at University of Chicago.